SILVERARC CAPITAL MANAGEMENT, LLC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1816307
BOSTON, MA
Position in KALV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$57,902,072
+$18,704,117 QoQ
Shares Held
2,876,407
+18.5% QoQ
Ownership
5.40%
of shares outstanding
% of Portfolio
6.84%
of 13F equity value
Holder Rank
#6
of 182 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Derivatives in KALV
reported options exposure · as of Dec 31, 2023CallValue
$2,209,900
CallShares
180,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $782,503,784 across 55 Biotechnology names. KALV ranks #1 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KALV |
KalVista Pharmaceuticals, Inc.
This page
|
2,876,407 | $57,902,072 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
654,746 | $54,946,284 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,314,189 | $50,583,134 | |
| 4 | CELC |
Celcuity Inc.
|
357,903 | $40,851,048 | |
| 5 | IMNM |
Immunome Inc.
|
1,850,278 | $40,465,579 | |
| 6 | KOD |
Kodiak Sciences Inc.
|
991,930 | $37,812,371 | |
| 7 | NUVL |
Nuvalent, Inc.
|
354,914 | $36,360,939 | |
| 8 | ABVX |
Abivax S.A.
|
302,530 | $33,686,715 |
All Filings in KALV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,902,072 | 2,876,407 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $39,197,955 | 2,427,118 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,605,944 | 1,363,378 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,712,693 | 1,832,171 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,606,275 | 1,698,984 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,185,105 | 612,173 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,653,381 | 574,558 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,607,201 | 560,883 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,655,630 | 561,183 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,209,900 | 180,400 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $1,368,741 | 111,734 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,107,752 | 530,400 | Call | Sole | 2023-11-13 | |
| 2023-09-30 | $2,204,634 | 228,934 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,484,572 | 720,508 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,687,055 | 723,544 | Shares | Sole | 2023-05-15 | |
| 2021-06-30 | $356,572 | 14,882 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,284,500 | 50,000 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||